In these patients, the observed deficiency can lead to an increased risk of osteoporosis and osteopenia; this risk is further exacerbated by analogous molecules of somatostatin administered to some of these patients, causing a reduced adsorption of vitamin D taken with the diet [69]. This evidence concerns the gene SST and osteoporosis.